DK1611106T3 - Fremstilling af quinapril hydrochlorid - Google Patents

Fremstilling af quinapril hydrochlorid

Info

Publication number
DK1611106T3
DK1611106T3 DK04721968T DK04721968T DK1611106T3 DK 1611106 T3 DK1611106 T3 DK 1611106T3 DK 04721968 T DK04721968 T DK 04721968T DK 04721968 T DK04721968 T DK 04721968T DK 1611106 T3 DK1611106 T3 DK 1611106T3
Authority
DK
Denmark
Prior art keywords
preparation
quinapril hydrochloride
quinapril
hydrochloride
Prior art date
Application number
DK04721968T
Other languages
Danish (da)
English (en)
Inventor
Sandra Marie Jennings
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1611106T3 publication Critical patent/DK1611106T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK04721968T 2003-03-31 2004-03-19 Fremstilling af quinapril hydrochlorid DK1611106T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45901603P 2003-03-31 2003-03-31

Publications (1)

Publication Number Publication Date
DK1611106T3 true DK1611106T3 (da) 2006-12-27

Family

ID=33131855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04721968T DK1611106T3 (da) 2003-03-31 2004-03-19 Fremstilling af quinapril hydrochlorid

Country Status (22)

Country Link
US (1) US6858735B2 (de)
EP (1) EP1611106B1 (de)
JP (1) JP2006522092A (de)
KR (1) KR20050115323A (de)
CN (1) CN1747935A (de)
AR (1) AR043949A1 (de)
AT (1) ATE340161T1 (de)
AU (1) AU2004226154B2 (de)
BR (1) BRPI0408924A (de)
CA (1) CA2517451C (de)
CL (1) CL2004000541A1 (de)
DE (1) DE602004002473T2 (de)
DK (1) DK1611106T3 (de)
ES (1) ES2271868T3 (de)
MX (1) MXPA05010498A (de)
PL (1) PL1611106T3 (de)
PT (1) PT1611106E (de)
RS (1) RS20050597A (de)
RU (1) RU2298004C2 (de)
TW (1) TWI284637B (de)
WO (1) WO2004087671A1 (de)
ZA (1) ZA200505214B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053994A1 (en) * 2007-10-26 2009-04-30 Matrix Laboratories Limited Process for preparing pure amorphous quinapril hydrochloride
US10278742B2 (en) 2012-11-12 2019-05-07 DePuy Synthes Products, Inc. Interbody interference implant and instrumentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
WO2002018321A2 (en) * 2000-08-29 2002-03-07 Abbott Laboratories Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
US6541635B1 (en) * 2002-03-29 2003-04-01 Everlight Usa, Inc. Method for producing angiotensin converting enzyme inhibitor
CA2510773C (en) * 2002-12-16 2010-04-13 Lupin Limited Crystalline form of quinapril hydrochloride and process for preparing the same

Also Published As

Publication number Publication date
AU2004226154B2 (en) 2007-03-08
AU2004226154A1 (en) 2004-10-14
US6858735B2 (en) 2005-02-22
TW200424177A (en) 2004-11-16
TWI284637B (en) 2007-08-01
CL2004000541A1 (es) 2005-02-04
WO2004087671A1 (en) 2004-10-14
US20040192613A1 (en) 2004-09-30
CA2517451C (en) 2009-04-21
KR20050115323A (ko) 2005-12-07
DE602004002473T2 (de) 2007-06-14
PT1611106E (pt) 2006-11-30
ES2271868T3 (es) 2007-04-16
MXPA05010498A (es) 2005-11-16
JP2006522092A (ja) 2006-09-28
RU2005130402A (ru) 2006-02-10
EP1611106B1 (de) 2006-09-20
ZA200505214B (en) 2008-08-27
CA2517451A1 (en) 2004-10-14
RU2298004C2 (ru) 2007-04-27
AR043949A1 (es) 2005-08-17
PL1611106T3 (pl) 2007-01-31
ATE340161T1 (de) 2006-10-15
EP1611106A1 (de) 2006-01-04
BRPI0408924A (pt) 2006-04-04
DE602004002473D1 (de) 2006-11-02
RS20050597A (en) 2007-09-21
CN1747935A (zh) 2006-03-15

Similar Documents

Publication Publication Date Title
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
DK3395338T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1730151T4 (da) Fremgangsmåde til fremstilling af oxycodonhydrochlorid med mindre end 25 ppm 14-hydroxycodeinon
DK1791820T3 (da) Enantioselektiv fremstilling af quinolinderivater
NO20054868D0 (no) CaSr antagonist
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK2172205T3 (da) Farmaceutisk formulering bestående af lanthan-forbindelser
DK1778618T3 (da) Syntese af triethylentetraminer
DK1575565T3 (da) Tablet med modificeret frigivelse af bupropion-hydrochlorid
DK1992697T3 (da) Fremstilling af TNFR-Fc
DK1587542T3 (da) Anvendelse af anti-CD100-antistoffer
DK1487840T3 (da) Krystallinsk polymorf form af irinotecan hydrochlorid
DK1516540T3 (da) Anvendelse af vitamin D-forbindelser
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
NO20043305D0 (no) Preparation of lodixanol
DK1682541T3 (da) Fremgangsmåde til fremstilling af tiotropiumsalte
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK2253619T3 (da) Aminsalt af carbostyrilderivat
DK1888613T3 (da) Fremgangsmåde til fremstilling af thiophenglycosidderivater
DK1654280T3 (da) Fremstilling af somatostatinpeptider
DK1768980T3 (da) Forbedret fremgangsmåde til fremstilling af mirtazapin
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer
DK1611106T3 (da) Fremstilling af quinapril hydrochlorid